Could a simple blood test predict statin muscle pain?
NCT ID NCT07511686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed observational study from Latvia looked at whether statin-related muscle symptoms are linked to problems in fat metabolism in muscle cells. Researchers measured acylcarnitine levels in blood and muscle samples from 38 adults, comparing those with statin-related muscle pain, those taking statins without symptoms, and people not taking statins. The goal was to see if acylcarnitine levels could help explain or predict muscle side effects from statins.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help explain why some people get muscle pain from statins and point toward ways to predict or manage this side effect.
- What could go wrong
- This is a small, observational study (38 participants) that only measures biological markers, not a treatment. Results may not apply to all populations or lead to direct clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STATIN ADVERSE REACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Latvia (Faculty of Medicine and Institute of Cardiology and Regenerative Medicine)
Riga, Latvia
More trials for these conditions
Other studies related to the condition(s) this trial covers.